​

LAVA Therapeutics (LVTX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

LVTX Stock Forecast

LAVA Therapeutics (LVTX) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 525.00% increase from the last price of $0.96.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $0.96

LVTX Stock Rating

LAVA Therapeutics stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (66.67%), 1 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 1 2 0 Strong Sell Sell Hold Buy Strong Buy

LVTX Forecast vs Benchmarks

TypeNameUpside
StockLAVA Therapeutics525.00%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$6.00
Last Closing Price$0.96$0.96$0.96
Upside/Downside--525.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25112--4
Dec, 24222--6
Nov, 2432---5
Oct, 2432---5
Sep, 2432---5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 28, 2024Arthur HeH.C. Wainwright$6.00$1.88219.15%525.00%
Mar 20, 2024Roger SongJefferies$6.00$3.0795.44%525.00%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jun 28, 2024H.C. WainwrightBuyBuyhold
Sep 27, 2022SVB LeerinkOutperformOutperformhold
Sep 16, 2022JMP SecuritiesMarket Performinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.30$-1.23$-1.57-----
Avg Forecast$-1.98$-1.18$-1.64$-1.11$-1.31$-0.62$-0.46$-0.46
High Forecast$-1.98$-1.18$-2.29$-1.48$-1.38$-0.97$-0.53$-0.46
Low Forecast$-1.98$-1.18$-0.98$-0.92$-1.23$-0.35$-0.33$-0.46
Surprise %16.16%4.24%-4.27%-----

Revenue Forecast

$0 $6M $12M $18M $24M $30M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.00M$19.39M$6.77M-----
Avg Forecast$4.39M$22.24M$5.82M$7.48M$9.65M$11.53M$3.80M$25.16M
High Forecast$4.39M$22.24M$2.53M$7.48M$9.65M$11.53M$3.80M$25.16M
Low Forecast$4.39M$22.24M$12.40M$7.48M$9.65M$11.53M$3.80M$25.16M
Surprise %13.82%-12.80%16.30%-----

Net Income Forecast

$-65M $-53M $-41M $-29M $-17M $-5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-45.35M$-31.91M$-41.97M-----
Avg Forecast$-53.03M$-31.61M$-38.14M$-24.75M$-35.53M$-17.58M$-11.51M$-12.19M
High Forecast$-53.03M$-31.61M$-61.20M$-39.50M$-36.95M$-25.80M$-14.23M$-12.19M
Low Forecast$-53.03M$-31.61M$-26.09M$-24.59M$-32.97M$-9.36M$-8.80M$-12.19M
Surprise %-14.49%0.94%10.05%-----

LVTX Forecast FAQ

Is LAVA Therapeutics stock a buy?

LAVA Therapeutics stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LAVA Therapeutics is a favorable investment for most analysts.

What is LAVA Therapeutics's price target?

LAVA Therapeutics's price target, set by 3 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 525.00% change from the previous close price of $0.96.

How does LAVA Therapeutics stock forecast compare to the average forecast of its sector, industry, and investment themes?

LAVA Therapeutics stock forecast shows a 525.00% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for LAVA Therapeutics over the past three months?

  • January 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 60.00% Strong Buy, 40.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is LAVA Therapeutics’s EPS forecast?

LAVA Therapeutics's average annual EPS forecast for its fiscal year ending in December is -1.11 for 2024, a -29.30% decrease from the reported $-1.57 in 2023. The prediction for 2025 is $-1.31, $-0.62 for 2026, $-0.46 for 2027, and $-0.46 for 2028.

What is LAVA Therapeutics’s revenue forecast?

LAVA Therapeutics's average annual revenue forecast for its fiscal year ending in December is $7.48M for 2024, a 10.53% increase from the reported $6.77M in 2023. The forecast for 2025 is $9.65M, $11.53M for 2026, $3.8M for 2027, and $25.16M for 2028.

What is LAVA Therapeutics’s net income forecast?

For its fiscal year ending in December, LAVA Therapeutics's average annual net income forecast is $-24.747M for 2024, reflecting a -41.04% decrease from the reported $-41.974M in 2023. The projection for 2025 is $-35.529M, $-17.578M for 2026, $-11.514M for 2027, and $-12.19M for 2028.